Low-dose capecitabine plus trastuzumab as first-line treatment in patients 75 years of age or older with HER2-positive advanced gastric cancer: a pilot study-Reference-Cited by-同舟云学术

Low-dose capecitabine plus trastuzumab as first-line treatment in patients 75 years of age or older with HER2-positive advanced gastric cancer: a pilot study

Published:2015-10-19 Issue:6 Volume:76 Page:1267-1272
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Kim Young Saing,Sym Sun Jin,Baek Min Young,Park Inkeun,Hong Junshik,Ahn Hee Kyung,Park Jinny,Cho Eun Kyung,Lee Woon Ki,Chung Min,Kim Hyung-Sik,Lee Jae Hoon,Shin Dong Bok

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-015-2881-x.pdf

Reference22 articles.

1. Jung KW, Won YJ, Kong HJ, Oh CM, Seo HG, Lee JS (2013) Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010. Cancer Res Treat 45:1–14

2. Van Cutsem E, Haller D, Ohtsu A (2002) The role of chemotherapy in the current treatment of gastric cancer. Gastric Cancer 5(Suppl 1):17–22

3. Wagner AD, Grothe W, Haerting J, Kleber G, Grothey A, Fleig WE (2006) Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data. J Clin Oncol 24:2903–2909

4. Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, Lordick F, Ohtsu A, Omuro Y, Satoh T, Aprile G, Kulikov E, Hill J, Lehle M, Ruschoff J, Kang YK, To GATI (2010) Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 376:687–697

5. Yancik R, Ries LA (2004) Cancer in older persons: an international issue in an aging world. Semin Oncol 31:128–136

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. State of the scientific evidence and recommendations for the management of older patients with gastric cancer;Journal of Geriatric Oncology;2023-11

2. Advanced oesophago-gastric adenocarcinoma in older patients in the era of immunotherapy. A review of the literature;Cancer Treatment Reviews;2021-11

3. Targeted agents in older patients with gastrointestinal cancers – An overview;Journal of Geriatric Oncology;2021-11

4. Recent Advances in Systemic Treatments for HER-2 Positive Advanced Gastric Cancer;OncoTargets and Therapy;2021-07

5. FOLFIRINOX for the Treatment of Advanced Gastroesophageal Cancers;JAMA Oncology;2020-08-01